Sequence Similarity Clusters for the Entities in PDB 1I8K

Entity #1 | Chains: A
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN protein, length: 107 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 37954
95 % 1 2 32312 Flexibility: Low
Max RMSD: 0.8, Avg RMSD: 0.8
PDBFlex
90 % 1 2 30925
70 % 1 2 27647
50 % 46 347 17
40 % 52 391 27
30 % 744 7768 1
Entity #2 | Chains: B
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN protein, length: 124 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 34431
95 % 1 2 30360 Flexibility: No
Max RMSD: 0.3, Avg RMSD: 0.3
PDBFlex
90 % 1 2 29112
70 % 94 456 9
50 % 116 682 6
40 % 616 6258 1
30 % 745 7768 1
Entity #3 | Chains: C
EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII PEPTIDE ANTIGEN protein, length: 12 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 6CNW 1 A humanized antibody SD84h 37965
2 5IVN 1 A BC2-nanobody 30538
3 5E7B 1 A nanobody nano-L06 9838
4 2P45 2 B ANTIBODY CAB-RN05 9838
5 2X1Q 1 A, B GELSOLIN NANOBODY 9844
6 5U64 1 B VHH-28 9838
7 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
8 4B41 1 A, B ANTIBODY G7 9844
9 5IMM 1 B Nanobody 9835
10 5NLU 1 A single domain llama antibody Nb36 9844
11 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
12 5IMK 1 B Nanobody 9835
13 6CWK 1 A Anti-Ricin antibody 30538
14 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
15 4B50 1 A 2H10 LLAMA VHH 9844
16 6DBA 1 A, B nanobody VHH R303 9838
17 2XT1 2 B CAMELID VHH 9 30538
18 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
19 5J1S 3 C VHH domain BS-2 30538
20 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
21 5J1T 3 C VHH domain BS-2 30538
22 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
23 2X1O 1 A, B GELSOLIN NANOBODY 9844
24 4QGY 1 A, B nanobody n25, VH domain 9844
25 5VNV 1 A Nb.b201 32630
26 5DXW 1 A PD-L1 nanobody 10090
27 4N9O 2 B Nanobody Nb484 Nb484 9844
28 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
29 1T2J 1 A M12-Variable Heavy domain 9606
30 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
31 6DBF 2 B InlB specific VHH R303 9838
32 6DBG 2 C, D VHH R303 9838
33 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
34 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
35 4KML 2 B Nanobody 9844
36 4Z9K 2 B VHH2(F5) antibody 30538
37 5LMW 1 A Nanobody 9844
38 5NM0 1 A, B, C, D Nb36 9844
39 6H6Y 2 E, F, G, H Nanobody (VHH) Nano-7 30538
40 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
41 4PPT 1 A Engineered single domain VHH antibody 9844
42 3R0M 1 A, B Llama VHH A12 9844
43 3ZKQ 2 D XA4813 9844
44 4I13 2 B Protein ca1697 (nanobody) 9844
45 5C2U 1 B Nanobody Nanobody 9838
46 1XFP 1 A heavy chain antibody VHH domain 9838
47 4POY 1 A VHH-metal 9844
48 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
49 5NLW 1 A nanobody Nb36 9844
50 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
51 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
52 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
53 3G9A 2 B Minimizer 9838
54 2P43 2 B ANTIBODY CAB-RN05 9838
55 4KRN 1 A Nanobody/VHH domain EgA1 9844
56 4GFT 2 B Nanobody 9844
57 4TVS 2 a, b VHH Domain BS-1 30538
58 4W6Y 2 B Nanobody NbFedF9 9844
59 6EZW 1 B VHH antibody BCD090-M2 9844
60 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
61 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
62 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
63 5O02 2 C Nanobody (VHH) Nano-4 30538
64 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
65 4X7F 2 C, D Nano-25 Nanobody 30538
66 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
67 4LGR 2 B Camelid nanobody (VHH3) 30538
68 5J57 2 B VHH single chain antibody V5E1 30538
69 5OMM 2 C Nanobody (VHH) Nano-14 30538
70 5E03 1 A mouse CTLA-4 nanobody 10090
71 5LZ0 1 A, B PorM nanobody 9844
72 6DBE 1 A, B nanobody VHH R303 9844
73 2XXC 1 B CAMELID VHH 9 30538
74 3QYC 1 A, B VH domain of IgG molecule 9606
75 5VAK 2 B Nb914 Nanobody 9844
76 2XXM 2 B CAMELID VHH 9 30538
77 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
78 5JDS 1 B Nanobody 9835
79 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
80 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
81 5FWO 1 A NANOBODY 9844
82 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
83 3B9V 1 A, B, C, D heavy chain variable domain 9606
84 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
85 5N88 1 A, H VH59 antibody 9606
86 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
87 4POU 2 B VHH Antibody 9844
88 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
89 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
90 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
91 6H70 2 C, D Nanobody (VHH) Nano-62 30538
92 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
93 2P42 2 B, D ANTIBODY CAB-RN05 9838
94 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
95 4QLR 1 A, B Llama nanobody n02 VH domain 9844
96 5J56 2 B VHH single chain antibody V1C7 30538
97 4NBX 2 B A20.1 VHH 9844
98 4HEP 2 G vHH17 domain 9844
99 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
100 5IML 2 B Nanobody 9835
101 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
102 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
103 5M2J 2 D Anti-(ED-B) scFV 9606
104 5IVO 1 A BC2-nanobody 30538
105 4NBZ 2 B, D A26.8 VHH 9844
106 2P44 2 B ANTIBODY CAB-RN05 9838
107 5TP3 1 A, B F-VHH-4 9844
108 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
109 4LHJ 2 B Camelid antibody 30538
110 4BEL 2 D, E XA4813 9844
111 5M7Q 1 A, B Nanobody NbD2 9838
112 5H8D 1 A VHH nanobody 9844
113 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
114 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
115 3DUR 2 B, D Ig-like protein 10090
116 2XV6 2 B, D CAMELID VHH 9 30538
117 5VM0 1 A, B Camelid Nanobody VHH T9 9844
118 4ZG1 1 A, B, C, D, E, F NB17 9844
119 4I1N 2 B Protein ca1697 (nanobody) 9844
120 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
121 6F0D 1 A, B VHH antibody BCD090-M2 9844
122 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
123 4W6X 2 B Nanobody NbFedF7 9844
124 5JA9 2 A, B Nanobody 6 9844
125 1JTP 1 A, B Single-Domain Antibody VH DOMAIN FRAGMENT 9838
126 1OP9 1 A HL6 camel VHH fragment 9838
127 2P4A 2 B, D ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
128 4S11 1 A GELSOLIN NANOBODY 9844
129 4WEN 2 B Anti-F4+ETEC bacteria VHH variable region 9844
130 2YC1 1 A, D SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN 9606
131 5HGG 2 S, T Camelid Derived Antibody Fragment, Nb4 30538
132 6APQ 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
133 1SHM 1 A, B, D, E ANTIBODY RIG RIG VHH 9844
134 4Y7M 1 A, B Hi113 protein 9844
135 5JMO 2 C, D camelid VHH fragment 9838
136 4B5E 1 A, B PS2-8 9844
137 4X7C 2 C, D Nano-85 Nanobody VHH 30538
138 3EBA 1 A CAbHul6 9838
139 3ZHD 1 A, B MG8-4 SCAFFOLD ANTIBODY HUMAN HEAVY CHAIN DOMAIN 9606
140 1WZ1 2 H Ig heavy chain Fv fragment(residues 1-123) 10090
141 4I0C 2 C, D cAbHuL5 antibody 9838
142 6H1F 1 A gelsolin nanobody, Nb11 9844
143 5BOP 1 A, C Nanobody 9844
144 4DKA 1 A, B single domain antibody VHH 9844
145 5O05 1 C, D Nanobody (VHH) Nano-42 30538
146 1OHQ 1 A, B IMMUNOGLOBULIN FV FRAGMENT, RESIDUES 1-120 9606
147 1DSF 2 H ANTICANCER ANTIBODY B1 FV 10090
148 3DUU 2 B, D Ig-like protein 10090
149 3K74 2 B Nanobody 9844
150 5M15 2 C, D Synthetic nanobody L2_D09, (a-MBP#3) 32630
151 1SJV 1 A r9 llama VHH single domain antibody 9844
152 6CK8 1 A, B, C Llama antibody SD38 9844
153 4M3J 1 A, B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
154 5VL2 1 A, B, C, D, E, F, G, H T4 nanobody 9844
155 6GZP 1 A Nanobody 9844
156 2UZI 1 H ANTI-RAS FV HEAVY CHAIN 9606
157 6H6Z 2 C, D Nanobody (VHH) Nano-62 30538
158 4W68 1 A, B Single domain antibody 9844
159 6FYS 1 A, B, C, D, E, F, G, H Single domain antibody SD83 9844
160 1JTT 1 A Vh Single-Domain Antibody VH domain fragment 9838
161 1CFV 2 H MONOCLONAL ANTIBODY FV4155 FV FRAGMENT 10090
162 3EAK 1 A, B NbBCII10-FGLA 9838
163 1KXT 2 B, D, F IMMUNOGLOBULIN VHH FRAGMENT 9838
164 4ORZ 3 C single domain antibody sdAb19 9844
165 4UU9 1 A, H MEDI7814 VARIABLE DOMAIN HEAVY CHAIN 9606
166 6EY6 2 I, J, K, L, M, N, O, P nb130 9844
167 2VYR 2 E, F, G, H, I, J, K, L HUMAN SINGLE DOMAIN ANTIBODY 9606
168 1BFV 2 H FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
169 5C1M 2 B Nanobody 39 9844
170 5F7K 2 C, D Nanobody Nb-ER19 9844
171 5LMJ 1 A, B, C, D nanobody 9844
172 5E1H 2 B F8(JOB10) VHH antibody 30538
173 1F2X 1 K, L ANTIBODY HEAVY CHAIN 9838
174 4OCM 3 C, F Nb1 9844
175 5HDO 1 A, B, C, D Anti-HCV NS3/4A serine protease immoglobulin heavy chain 9838
176 4X7E 2 C, D Nano-85 Nanobody 30538
177 1ZV5 2 A immunoglobulin heavy chain antibody variable domain VHH D2-L29 9838
178 5O03 2 C, D Nanobody (VHH) Nano-32 9844
179 4Y8D 2 C, D nanobody 9844
180 4EIZ 2 C, D Nb113 Camel antibody fragment 9844
181 1I3U 1 A ANTIBODY VHH LAMA DOMAIN 9844
182 1I3V 1 A, B ANTIBODY VHH LAMA DOMAIN 9844
183 4C58 2 B NANOBODY 9844
184 3DV6 2 B Ig-like protein 10090
185 4LAJ 3 H, I, L, M Llama single domain antibody, JM4 9844
186 4XVJ 2 H antibody heavy chain variable domain 9606
187 4IDL 1 A Single Domain Antibody VHH A9 9844
188 1FVC 2 B, D IGG1-KAPPA 4D5 FV (HEAVY CHAIN) 9606
189 3K7U 1 A Antibody 9844
190 4NBY 2 B, C A20.1 VHH 9844
191 4X7D 2 C, D Nano-85 Nanobody VHH 9844
192 5VAN 2 B Nb914 Nanobody 9844
193 5F7N 2 C, D Nanobody Nb-ER19 30538
194 5OCL 1 A, C, F, H anti-llama nanobody 30538
195 5OCL 2 B, D, E, G anti-vglut nanobody 9844
196 2A9M 2 H, I fluorescein-scfv heavy chain 9606
197 5E5M 2 B, D, F, H mouse anti CTLA-4 nanobody 10090
198 1SJX 1 A immunoglobulin VH domain 9844
199 3ZKS 2 D XA4813 9844
200 6FYW 3 C Single domain antibody SD83 EVQLVESGGGLVQPGGSLRLSCAATGFTLENKAIGWFRQTPGSEREGVLCISKSGSWTYYTDSMRGRFTISRDNAENTVYLQMDSLKPEDTAVYYCATTTAGGGLCWDGTTFSRLASSWGQGTQVTVSS 9844
201 6H72 2 C, D Nanobody (VHH) Nano-94 30538
202 5MY6 2 B Nanobody 2Rs15d 9838
203 3DUS 2 B, D Ig-like protein 10090
204 5M2I 2 G, H, I, J, K, L VHH1 9844
205 5MWN 2 D, E, F llama nanobody raised against TssK, nbK18 9844
206 5MWN 3 N llama nanobody raised against TssK, nbK27 9844
207 3ZHK 1 A, B MG2X1 SCAFFOLD ANTIBODY 9606
208 3K1K 2 C, D Enhancer 9838
209 4U7S 1 A, B sdAb A3 9844
210 4U3X 1 A, C Human VH domain antibody 9606
211 4W81 1 A Single Domain Antibody 9844
212 5GRV 1 L homo-specific diabody heavy chain 9606
213 5JMR 1 A, B camelid VHH fragment 9838
214 4W70 1 A Single Domain Antibody 9844
215 2GSG 2 B, D monoclonal antibody heavy chain variable domain 10090
216 4BFB 2 D, E XA4813 9844
217 5LHR 2 B Camelid-Derived Antibody Fragment Nb22 30538
218 1I8I 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
219 4LHQ 2 B, D Camelid nanobody 30538
220 3DV4 2 B Ig-like protein 10090
221 6H71 2 C, D Nanobody (VHH) Nano-94 30538
222 3ZKX 2 B XA4813 9844
223 3ZKX 3 C XA4815 9844
224 3ZLQ 2 C, D XA4813 9844
225 4NC0 2 B A26.8 VHH 9844
226 1IGM 2 H IGM-KAPPA POT FV (HEAVY CHAIN) 9606
227 5GS1 2 B, N, P, R heavy chain 9606
228 5F7Y 3 C, D Nanobody Nb-ER19 9844
229 5IMO 1 B Nanobody 9835
230 5U65 1 A, B VHH-5 9838
231 4TYU 1 A, B Single Domain Antibody 9844
232 4AQ1 2 B, D NBKB6 VHH 9844
233 6FV0 2 F nanobody 9844
234 4EIG 2 B CA1698 camel antibody fragment 9844
235 3EHB 3 C FV fragment Chain H 10090
236 6B20 3 E, F Nanobody against G protein beta gamma dimer 9844
237 3HB3 3 C ANTIBODY FV FRAGMENT 10090
238 2X89 1 A, B, C ANTIBODY 9838
239 5M2M 2 D, E, F, H, J, N Llama nanobody VHH3 9844
240 5O04 2 E, F Nanobody (VHH) Nano-26 30538
241 5O04 3 C, D Nanobody (VHH) Nano-85 30538
242 5LBS 2 H, I BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 ScFv fragment, heavy chain 9606
243 3P9W 2 B, D, F, H human VEGF 9606
244 5F8R 2 C, D Nanobody Nb-ER19 9844
245 4OCL 3 C, F Nb1 9844
246 4RAV 2 A, C single-chain Fv, VH 9606
247 5XJ4 2 H durvalumab-VH 9606
248 4X4X 1 A, C Human Variable Heavy Chain of Herceptin 9606
249 4IOS 2 D, E, F, G Llama nanobody 11 9844
250 5LHN 2 B Camelid-Derived Antibody Fragment Nb7 30538
251 2BFV 2 H FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
252 3ZHL 1 A MG8-14 SCAFFOLD ANTIBODY 9606
253 4OCN 3 C, F Nb1 9844
254 4GRW 3 E, G Nanobody 124C4 9844
255 4GRW 4 F, J Nanobody 37D5 9844
256 4GRW 5 H, I Nanobody 22E11 9844
257 5G5R 2 B NANOBODY NB330 SELECTED FROM LLAMA GLAMA 9844
258 4NC2 2 B B39 VHH 9844
259 2WZP 2 D, E, F, J, K, L CAMELID VHH5 9844
260 5LHQ 2 B Camelid-Derived Antibody Fragment Nb7 30538
261 6EY0 2 E, G, H llama nanobody nb01 9844
262 6EY0 3 F llama nanobody nb01 9844
263 5F9A 2 C Nanobody Nb-ER19 9844
264 2OTW 2 B, D Fv heavy chain variable domain VH 10090
265 3STB 1 A, B single domain antibody VHH 9844
266 4W6W 2 B NbFedF6 9844
267 5JA8 2 B, D, F, H Nanobody 2 9844
268 2YBR 1 A, D, G SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN, RESIDUES 1-117 9606
269 5U4M 2 B V1C7 VHH antibody 30538
270 5O0W 2 E, F, G, H Nb474 30538
271 4Y5V 1 A, D, G diabody 305 VH domain 9606
272 1DQL 2 H IGM MEZ IMMUNOGLOBULIN HEAVY CHAIN VARIABLE DOMAIN FRAGMENT 9606
273 1JTO 1 A, B Vh Single-Domain Antibody VH domain fragment 9838
274 6FYU 3 C, F, I Single domain antibody SD36 9844
275 5F97 2 E, F, G, H Nanbody Nb-ER19 9844
276 3K80 1 A, B Antibody 9844
277 5VAQ 2 B Nb914 Nanobody 9844
278 1QD0 1 A VHH-R2 ANTI-RR6 ANTIBODY VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
279 5F8Q 2 C, D Nanobody Nb-ER19 9844
280 4U05 1 A, B Single Domain Antibody 9844
281 5F9D 2 C Nanobody Nb-ER19 9844
282 4X4Y 1 A, C Human Variable Heavy Chain of Herceptin 9606
283 4LGP 2 B, D VHH1 camelid nanobody 30538
284 2P48 2 B ANTIBODY CAB-RN05 9838
285 5U4L 2 B V1C7 VHH antibody G29R variant 30538
286 5F7M 2 C, D Nanobody Nb-ER19 9844
287 5DA4 1 A, B, C Nanobody recognizing the membrane protein SLC26Dg 9844
288 5F7W 2 C, D Nanobody Nb-ER19 9844
289 1MEL 1 A, B VH SINGLE-DOMAIN ANTIBODY 9838
290 4NC1 2 C, D A20.1 VHH 9844
291 4NC1 3 E, F A26.8 VHH 9844
292 5M30 2 D, E, F Anti-vesicular stomatitis virus N VHH 30538
293 4WEU 1 D, E Anti-F4+ETEC bacteria VHH variable region 9844
294 5E7F 1 A, B, C nanobody L06 9838
295 2P46 2 B, D ANTIBODY CAB-RN05 9838
296 5YOY 3 G, H, I, P, Q, R Golimumab heavy chain variable region 9606
297 5LWF 2 C, D Camelid heavy-chain antibody variable fragment cAb-G10S 9844
298 5LHP 2 B Camelid-Derived Antibody Fragment 30538
299 5USF 2 C, D Immunoglobulin heavy chain variable region 9844
300 5SV4 1 A, B Single Domain Antibody A3C8 9844
301 4LGS 2 B Camelid nanobody (VHH4) 30538
302 3QXV 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
303 2P47 2 B ANTIBODY CAB-RN05 9838
304 4KRM 2 B, D, F, H, J, L Nanobody/VHH domain 7D12 9844
305 4P2C 3 G, H, I, J, K Nanobody 1, Anti-F4+ETEC bacteria VHH variable region 9844
306 1AR1 3 C ANTIBODY FV FRAGMENT 10090
307 3EZJ 2 B, D, F, H NANOBODY NBGSPD_7 9844
308 5VNW 2 C, D Nb.b201 32630
309 6FE4 2 F, G, H, I, J Nb113 30538
310 5NML 1 A, B, C, D, E, F, G, H, I, J Nanobody Nb36 Ser85Cys 9844
311 2CJU 1 H NQ16-113.8 ANTI-PHOX ANTIBODY 10090
312 6CWG 2 B, D VHH antibody 30538
313 5HVF 2 B VHH-i83 30538
314 4PGJ 1 A, C Human heavy chain domain antibody 9606
315 4KDT 1 A, B Nanobody24 9835
316 6H02 2 B LAMA nanobody NB106 Lama nanobody generated against Human Mediator subunit MED23 9844
317 3CFI 3 C, F, I, L Nanobody NBEPSIJ_11 9844
318 2VH5 1 H ANTI-RAS FV HEAVY CHAIN 9606
319 4S10 1 A, B GELSOLIN NANOBODY GELSOLIN NANOBODY 9844
320 6FYT 3 I Single domain antibody SD38 9844
321 5MJE 2 B Nanobody 8 9844
322 3OGO 2 E, F, G, H GFP-nanobody 9838
323 4C59 2 B NANOBODY 9844
324 6H7N 3 C, D Camelid antibody fragment Nb6B9 9844
325 4DK6 1 A, B single domain antibody VHH 9844
326 5F93 2 C, D, F, H Nanobody Nb-ER19 9844
327 5F7L 2 B, D Nanobody Nb-ER14 9844
328 5HVG 2 B, D VHH-a204 30538
329 3UPC 1 A, B, C, D, E, F, G, H, I, J heavy chain variable domain 9606
330 4W2Q 1 A, C, E, G Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
331 5HVH 2 B VHH-a204 30538
332 5HVH 3 C VHH-i83 30538
333 4XT1 3 C nanobody 7 30538
334 5HM1 1 A, B, C lama VHH antibody 2E7 9844
335 5FUC 3 E, V VHH6 9838
336 5SV3 1 A, C Anti-Ricin A-chain Single Domain Antibody (sdAb) A3C8 9844
337 5OMN 2 C Nanobody (VHH) Nano-27 30538
338 4KRP 2 B Nanobody/VHH domain 9G8 9844
339 6FUZ 2 N nanobody 9844
340 4FHB 2 D Nb179 9844
341 4DK3 1 A, B single domain antibody VHH 9844
342 4KRL 1 B Nanobody/VHH domain 7D12 9844
343 4V1D 1 A SINGLE CHAIN ANTIBODY FRAGMENT LR, HEAVY CHAIN 9606
344 4V1D 4 D SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN 9606
345 1BZQ 2 K, L, M, N PROTEIN (ANTIBODY CAB-RN05) VARIABLE DOMAIN 9838
346 1YZZ 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 9838
347 6MXT 2 N nanobody Nb71 9844
348 4LDE 2 B Camelid Antibody Fragment 9844
349 4Y5Y 1 A, D diabody 330 VH domain 9606
350 6IBL 2 C, D Camelid antibody fragment Nb80 9844
351 5DMJ 2 B, E, G 3H65-5 domain antibody (dAb) 9606
352 6H7L 3 C, D Camelid antibody fragment Nb6B9 9844
353 3RJQ 2 B Llama VHH A12 9844
354 1ZMY 1 A Antibody cabbcII-10:lys3 N-terminus, 142 residues 9838
355 3AB0 2 B, E antibody ScFv fragment, heavy chain 10090
356 4N1H 2 B, D Camelid heavy-chain antibody variable fragment cAb-F11N 9844
357 6EQI 2 B Nb696 9844
358 2BSE 2 D, E, F LLAMA IMMUNOGLOBULIN VHH RECOGNITION DOMAIN, RESIDUES 1-123 9844
359 1YC8 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33-hu 9838
360 4KFZ 2 C, D Anti-LMO2 VH 9606
361 2UUD 1 H, J NQ10-1.12 ANTI-PHOX ANTIBODY 10090
362 5TOJ 2 D, E, F Single-domain antibody F-VHH-4 9844
363 6H7O 3 C, D Camelid antibody fragment Nb6B9 9844
364 4Y5X 1 A, D, G, J diabody 310 VL domain 9606
365 4YGA 2 B, D, F, H VHH-1B7 30538
366 2A9N 2 H, I fluorescein-scfv heavy chain 9606
367 5YY5 2 H Heavy chain 9606
368 5YY5 4 C Heavy chain 9606
369 5G5X 2 B NANOBODY NB330, SELECTED FROM LLAMA, C-TERMINAL 6XHIS- TAG 9844
370 5GRJ 1 H avelumab H chain 9606
371 6N4Y 2 E, F, G, H Nanobody 43 Nanobody 43 9844
372 5BOZ 2 G, H, I, J, K, L VHH single chain antibody E1 30538
373 4KRO 2 B Nanobody/VHH domain EgA1 9844
374 3DWT 1 A, B, C, D, E, F, G, H cAbBCII-10 9838
375 5TJW 2 K NP-specific inhibitory VHH 30538
376 1QLE 5 H HEAVY CHAIN ANTIBODY FV FRAGMENT 10090
377 6H7M 3 C, D Camelid antibody fragment Nb6B9 562
378 4LDL 2 B Camelid Antibody Fragment 9844
379 4LDO 2 B Camelid Antibody Fragment 9844
380 5XJ3 1 A, D, G, J ipilimumab-VH 9606
381 3SN6 5 N Camelid antibody VHH fragment 9844
382 5M94 2 B, D CAMELID ANTIBODY FRAGMENT, NANOBODY 9844
383 4W2O 1 A, C, E, G Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
384 5O8F 2 K, O Nanobody Nb25 9844
385 5O8F 3 L, M, N Nanobody Nb25 9844
386 5NQW 2 C, D 026 9844
387 5C3L 4 D Nanobody Nb15 Nanobody 9838
388 1G6V 2 K ANTIBODY HEAVY CHAIN CAB-CA05, VARIABLE DOMAIN 9838
389 5UK4 2 a, b, c, d, e, f, g, h, i, j, k, l, m, n, o, p, q, r, s, t Anti-vesicular stomatitis virus N VHH GGLPETGGHHHHHH Sortase A recognition mofiv and HIS TAG 30538
390 5FV2 1 A, B, C VH DOMAIN ANTIBODY VH DOMAIN ANTIBODY 9606
391 4WGV 2 B, D Camelid antibody fragment, nanobody 9844
392 6H7J 3 C, D Camelid antibody fragment Nb80 9844
393 5OJM 2 K, L, M, N, O Nanobody Nb25 9844
394 6B73 2 C, D Nanobody 9844
395 4PIR 2 F, G, H, I, J VHH15 9844
396 6C5W 2 C, E nanobody 32644
397 4QKX 2 B R9 protein 9844
398 5JQH 2 C, D Nanobody60, Nb60 9844
399 6C9W 2 B Nanobody9047 Full 9844
400 5DA0 2 B Nanobody 9844
401 6GCI 2 B Nanobody Nanobody selected against the BKA-inhibited ADP/ATP carrier 9844
402 3P0G 2 B Camelid Antibody Fragment NANOBODY 9844
403 5M95 2 B, D CAMELID ANTIBODY FRAGMENT, NANOBODY 9844
404 4WGW 2 B, D Camelid antibody fragment, nanobody 9844
405 5IHL 2 B, E, G, I 3H56-5 domain antibody (dAb) 3H56-5 dAb 9606
406 4MQS 2 B Nanobody 9-8 9844
407 5WB2 3 D nanobody B1 32630
408 1QFW 6 I ANTIBODY (ANTI BETA SUBUNIT) (HEAVY CHAIN) FV 10090
409 3K81 2 A, B Single strand antibody VHH domain single domain antibody VHH 9844
410 4MQT 2 B Nanobody 9-8 9844
411 5TOK 2 D, E, F Single-domain antibody F-VHH-L66 9844
412 6CNV 3 C SD84h 32630
413 6N50 2 E Nanobody 43 9844
414 5EUL 4 V AYC08 30538
415 5GXB 2 B nanobody 30538
416 5NBD 2 C Nanobody 9844
417 5H8O 1 A VHH nanobody 9844
418 4KSD 2 B R2 protein 9844
419 5DFZ 4 E Nanobody binding S. cerevisiae Vps34 9844
420 5UKB 1 a, b, c, d, e Anti-vesicular stomatitis virus N VHH GGLPETGGHHHHHH Sortase A recognition motif and HIS tag. 30538
421 5TD8 5 E nanobody 30538
422 6NIY 2 N Nanobody35 9844
423 6IYN 1 A Nb26 30538
424 6N51 2 C, D Nanobody 43 9844
425 6I53 4 G Megabody38 9844
426 6MID 3 H monoclonal antibody ZIKV-195 heavy chain Fab variable domain 9606
427 6E3Y 2 N Nanobody 35 9844
428 6A96 1 K, L, O Nb25 9844
429 6DZL 4 G, H, I Fv domain of ADI-15878 Fab heavy chain 9606
430 6DZM 4 G, I, J Antibody ADI-15878 Fab, heavy chain 9606
431 6GV4 5 H AT12-015 antibody variable heavy polypeptide chain 9606
432 6BSP 1 A U4 Heavy chain 10090
433 6B3J 6 N Nanobody 35 9844
434 6EHG 3 C hC3Nb1 9844
435 5Y0A 2 D, F, H variable region of Fab ZKA190 heavy chain 9606
436 5XS7 2 H Heavy chain of Fab 1D5 10090
437 5VAI 6 N nanobody 35 9844
438 5UZ7 4 N NANOBODY 35 9844
439 5TSJ 10 1, 2 Human heavy chain domain antibody 9606
440 5KWL 4 7 VHH 10E 9838
441 5KTZ 4 7 VHH 12B 9838
442 5KU0 4 7 VHH 17B 9838
443 5KU2 4 7 VHH 7A 9838
444 5KEL 3 H, P, Q c2G4 variable Fab domain heavy chain 9606
445 5FOJ 1 A NANOBODY 9838
446 3JBC 5 7 nanobody VHH PVSP29F 9838
447 3JBD 5 7 nanobody VHH PVSP6A 9838
448 3JBE 5 7 nanobody VHH PVSS8A 9838
449 3JBF 5 7 nanobody VHH PVSP19B 9838
450 3JBG 5 7 nanobody VHH PVSS21E 9838
451 3JBA 2 H H16.U4 antibody heavy chain Fab variable domain 10090
452 4UDF 4 11, 15, 19, 1D, 1H, 1L, 1P, 1T, 1X, 21, 25, 29, 2D, 2H, 2L, 2P, 2T, 2X, 31, 35, 39, 3D, 3H, 3L, 3P, 3T, 3X, 41, 45, 49, 4D, 4H, 4L, 4P, 4T, 4X, 51, 55, 59, 5D, 5H, 5L, 5P, 5T, 5X, 61, 65, 69, 6D, 6H, 6L, 6P, 6T, 6X, 7D, 7H, 7L, 7P, 7T, 7X HUMAN MONOCLONAL ANTIBODY 9606
453 3IY5 2 B antibody fragment IGG2A (heavy chain) 10090
454 1IEH 1 A BRUC.D4.4 SINGLE DOMAIN ANTIBODY FROM A NAIVE LLAMA LIBRARY 9844
455 1G9E 1 A H14 9844
456 1VHP 1 A VH-P8 9606